Rao, Ravi D <br/><br/>
Safety of thrice-daily hyperfractionated radiation and BCNU for high-grade gliomas.  [electronic resource] 

 -  International journal of radiation oncology, biology, physics  Jun 2002 
 - 376-84 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>0360-3016 
<br/><br/><label>Standard No.: </label>10.1016/s0360-3016(02)02731-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents, Alkylating--administration & dosage<br/>Astrocytoma--drug therapy<br/>Brain Diseases--etiology<br/>Carmustine--administration & dosage<br/>Combined Modality Therapy<br/>Dose Fractionation, Radiation<br/>Drug Administration Schedule<br/>Female<br/>Glioma--drug therapy<br/>Gliosarcoma--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>Survival Rate<br/>Time Factors<br/>Treatment Outcome